Search Results - "Forsten, Aino"

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in healthy toddlers: a Phase II randomized study by Vesikari, Timo, Borrow, Ray, Forsten, Aino, Findlow, Helen, Dhingra, Mandeep S., Jordanov, Emilia

“…can lead to invasive meningococcal disease to which young children are particularly vulnerable. We assessed the immunogenicity and safety of Sanofi Pasteur's…”
Get full text

Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study by Piazza, Franco M., Virta, Miia, Paassilta, Marita, Ukkonen, Benita, Ahonen, Anitta, Esteves-Jaramillo, Alejandra, Forsten, Aino, Seppa, Ilkka, Ding, Jian, Neveu, David, Jordanov, Emilia, Dhingra, Mandeep S.

“…Booster doses of meningococcal conjugate vaccines induce long-term protection against invasive meningococcal disease. We evaluated the immunogenicity and…”
Get full text

An Open-Label, Randomized Study of a 9-Valent Human Papillomavirus Vaccine Given Concomitantly with Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccines to Healthy Adolescents 11–15 Years of Age by Kosalaraksa, Pope, Mehlsen, Jesper, Vesikari, Timo, Forstén, Aino, Helm, Klaus, Van Damme, Pierre, Joura, Elmar A, Ciprero, Karen, Maansson, Roger, Luxembourg, Alain, Sobanjo-ter Meulen, Ajoke

“…BACKGROUND:A 9-valent human papillomavirus (9vHPV) vaccine has recently been reported to be safe and highly efficacious against infection and disease related…”
Get full text

Safety and immunogenicity of an MF59® -adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly by Vesikari, Timo, Forstén, Aino, Herbinger, Karl-Heinz, Cioppa, Giovanni Della, Beygo, Jenny, Borkowski, Astrid, Groth, Nicola, Bennati, Mariaviviana, von Sonnenburg, Frank

“…Highlights ► Two doses of MF59-H5N1 vaccine were well tolerated. ► Two doses of MF59-H5N1 vaccine induced adequate levels of seroprotection against homologous…”
Get full text

Influenza vaccination in children primed with MF59®-adjuvanted or non-adjuvanted seasonal influenza vaccine by Vesikari, Timo, Forstén, Aino, Arora, Ashwani, Tsai, Theodore, Clemens, Ralf

“…Routine annual influenza immunization is increasingly recommended in young children. We compared the safety and immunogenicity of vaccination with trivalent…”
Get full text

A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2–10 y by Marie Van der Wielen, Jacqueline M. Miller, Timo Vesikari, Aino Forstén, Dominique Boutriau, Véronique Bianco

“…Incidence of meningococcal diseases is high in children, and effective vaccines are needed for this age group. In this phase II, open, controlled study, 309…”
Get full text

Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers by Vesikari, Timo, Forstén, Aino, Boutriau, Dominique, Bianco, Véronique, Van der Wielen, Marie, Miller, Jacqueline M.

“…Effective vaccines offering broad protection to toddlers, who are at high risk for invasive meningococcal disease, are needed. Here, the immunogenicity, safety…”
Get full text

A Combined Haemophilus influenzae Type B Neisseria meningitidis Serogroup C Tetanus Toxoid Conjugate Vaccine Is Immunogenic and Well-tolerated When Coadministered With Diphtheria, Tetanus, Acellular Pertussis Hepatitis B―inactivated Poliovirus at 3, 5 and 11 Months of Age: Results of an Open, Randomized, Controlled Study by VESIKARI, Timo, FORSTEN, Aino, GUISEPPINA DESOLE, Maria, FERRERA, Giuseppe, CAUBET, Magalie, MESAROS, Narcisa, BOUTRIAU, Dominique

“…This study evaluated the immunogenicity, reactogenicity and safety of the combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus…”
Get full text

Homologous and heterologous antibody responses to a one-year booster dose of an MF59®: Adjuvanted A/H5N1 pre-pandemic influenza vaccine in pediatric subjects by Vesikari, Timo, Forstén, Aino, Borkowski, Astrid, Gaitatzis, Nikolaos, Banzhoff, Angelika, Clemens, Ralf

“…Background: Primary immunization with two doses of MF59 ® -adjuvanted A/H5N1 influenza vaccine has been shown to be highly immunogenic and well tolerated in…”
Get full text

Long-term antibody persistence after a booster dose of quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in healthy 5-year-old children by Vesikari, Timo, Forsten, Aino, Laudat, France, Li, Ping, Van Der Wielen, Marie, Hezareh, Marjan, Perez, John L., Webber, Chris

“…•MenACWY-TT booster 4 y postvaccination in toddlers may afford long-term IMD protection.•Long-term MenACWY-TT antibody persistence against groups ACWY was…”
Get full text

Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same Vaccines by Vesikari, Timo, Forsten, Aino, Bianco, Veronique, Van der Wielen, Marie, Miller, Jacqueline M

“…We evaluated safety, immunogenicity and antibody persistence of meningococcal serogroups A, C, W and Y tetanus toxoid conjugate vaccine (MenACWY-TT) booster…”
Get full text

Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D–Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media—A Double-Blind Randomized Clinical Trial in Finland by Vesikari, Timo, Forsten, Aino, Seppä, Ilkka, Kaijalainen, Tarja, Puumalainen, Taneli, Soininen, Anu, Traskine, Magali, Lommel, Patricia, Schoonbroodt, Sonia, Hezareh, Marjan, Moreira, Marta, Borys, Dorota, Schuerman, Lode

“…After administering the 10-valent pneumococcal polysaccharide nontypeable Haemophilus influenzae protein D–conjugated vaccine (PHiD-CV) to children aged 2–18…”
Get full text

Antibody persistence up to 5 years after vaccination of toddlers and children between 12 months and 10 years of age with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine by Vesikari, Timo, Forsten, Aino, Bianco, Veronique, Van der Wielen, Marie, Miller, Jacqueline M

“…We studied the persistence of serum bactericidal antibody using rabbit and human complement (rSBA/hSBA, cut-offs 1:8) 5 y after a single dose of meningococcal…”
Get full text

Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical Trial by Vesikari, Timo, Finn, Adam, van Damme, Pierre, Leroux-Roels, Isabel, Leroux-Roels, Geert, Segall, Nathan, Toma, Azhar, Vallieres, Gerald, Aronson, Ronnie, Reich, Dennis, Arora, Samir, Ruane, Peter J, Cone, Clancy L, Manns, Michael, Cosgrove, Catherine, Faust, Saul N, Ramasamy, Maheshi N, Machluf, Nathalie, Spaans, Johanna N, Yassin-Rajkumar, Bebi, Anderson, David, Popovic, Vlad, Diaz-Mitoma, Francisco

“…There is a need for improved immunogenicity of hepatitis B virus (HBV) vaccines among young adults with risk of infection. To demonstrate manufacturing…”
Get full text

987. Repeated Exposure to an Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV): A Randomized, Observer Blind, Multicenter Study by Daly, Wendy, Ramsey, Keith, Forsten, Aino, Heijnen, Esther, Leav, Brett, Oberye, Janine, Zhang, Bin, Pacciarini, Filippo, Vesikari, Timo

Get full text

Long term persistence of anti-HBs antibodies after vaccination with a 3-antigen HBV vaccine compared to a single-antigen HBV vaccine by Vesikari, Timo, Forstén, Aino, Popovic, Vlad, Spaans, Johanna, Diaz-Mitoma, Francisco

Get full text

Safety and immunogenicity of an intramuscular quadrivalent influenza vaccine in children 3 to 8 y of age: A phase III randomized controlled study by Pepin, Stephanie, Szymanski, Henryk, Rochín Kobashi, Ilya Angélica, Villagomez Martinez, Sandra, González Zamora, José Francisco, Brzostek, Jerzy, Huang, Li-Min, Chiu, Cheng-Hsun, Chen, Po-Yen, Ahonen, Anitta, Forstén, Aino, Seppä, Ilkka, Quiroz, René Farfán, Korhonen, Tiina, Rivas, Enrique, Monfredo, Celine, Hutagalung, Yanee, Menezes, Josemund, Vesikari, Timo

“…A quadrivalent, inactivated, split-virion influenza vaccine containing a strain from both B lineages (IIV4) has been developed, but its safety and…”
Get full text

Antibody persistence to meningococcal serogroups A, C, W and Y in toddlers two years after vaccination with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate (MenACWY-TT) vaccine as measured by bactericidal antibody assays using rabbit or human complement by Vesikari, Timo, Forsten, Aino, Bianco, Veronique, Van der Wielen, Marie, Miller, Jacqueline M.

“…Long term protection against invasive meningococcal disease relies on persistence of bactericidal antibodies. We studied the persistence of serum bactericidal…”
Get full text

Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers by Timo Vesikari, Aino Forstén, Dominique Boutriau, Marie Van der Wielen, Jacqueline M. Miller, Véronique Bianco

“…Effective vaccines offering broad protection to toddlers, who are at high risk for invasive meningococcal disease, are needed. Here, the immunogenicity, safety…”
Get full text

A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in children aged 2-10 years by Vesikari, Timo, Forstén, Aino, Boutriau, Dominique, Bianco, Véronique, Van der Wielen, Marie, Miller, Jacqueline M.

“…Incidence of meningococcal diseases is high in children, and effective vaccines are needed for this age group. In this phase II, open, controlled study, 309…”
Get full text